Alector, Inc. (ALEC)
NASDAQ: ALEC · IEX Real-Time Price · USD
5.83
0.00 (0.00%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Alector Employees
Alector had 244 employees as of December 31, 2023. The number of employees decreased by 29 or -10.62% compared to the previous year.
Employees
244
Change (1Y)
-29
Growth (1Y)
-10.62%
Revenue / Employee
$395,107
Profits / Employee
-$494,316
Market Cap
561.92M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Castle Biosciences | 610 |
Quanterix | 441 |
National Research | 435 |
Pharming Group | 382 |
Verve Therapeutics | 255 |
iTeos Therapeutics | 157 |
Terns Pharmaceuticals | 66 |
Mind Medicine (MindMed) | 57 |
ALEC News
- 6 weeks ago - Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform - GlobeNewsWire
- 2 months ago - Alector to Participate in Upcoming Healthcare Conferences - GlobeNewsWire
- 5 months ago - Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call - GlobeNewsWire
- 5 months ago - Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer's Disease - GlobeNewsWire
- 5 months ago - FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN) - GlobeNewsWire
- 6 months ago - Alector Announces Closing of Public Offering - GlobeNewsWire
- 6 months ago - Alector Announces Pricing of Public Offering of Common Stock - GlobeNewsWire